Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 3124       
ORIGINAL ARTICLE
Year : 2020  |  Volume : 152  |  Issue : 1  |  Page : 82-87

Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients


1 Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India
2 Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India
3 Epidemiology Group, ICMR-National Institute of Virology, Pune, Maharashtra, India
4 Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India
5 ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India
6 Medical Department, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India

Correspondence Address:
Gajanan N Sapkal
Sapkal, Diagnostic Virology Group, ICMR-National Institute of Virology, Sus Road, Pashan, Pune 411 021, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmr.IJMR_2382_20

Rights and Permissions

Background & objectives: The global pandemic caused by SARS-CoV-2 virus has challenged public health system worldwide due to the unavailability of approved preventive and therapeutic options. Identification of neutralizing antibodies (NAb) and understanding their role is important. However, the data on kinetics of NAb response among COVID-19 patients are unclear. To understand the NAb response in COVID-19 patients, we compared the findings of microneutralization test (MNT) and plaque reduction neutralization test (PRNT) for the SARS-CoV-2. Further, the kinetics of NAb response among COVID-19 patients was assessed. Methods: A total of 343 blood samples (89 positive, 58 negative for SARS-CoV-2 and 17 cross-reactive and 179 serum from healthy individuals) were collected and tested by MNT and PRNT. SARS-CoV-2 virus was prepared by propagating the virus in Vero CCL-81 cells. The intra-class correlation was calculated to assess the correlation between MNT and PRNT. The neutralizing endpoint as the reduction in the number of plaque count by 90 per cent (PRNT90) was also calculated. Results: The analysis of MNT and PRNT quantitative results indicated that the intra-class correlation was 0.520. Of the 89 confirmed COVID-19 patients, 64 (71.9%) showed NAb response. Interpretation & conclusions: The results of MNT and PRNT were specific with no cross-reactivity. In the early stages of infection, the NAb response was observed with variable antibody kinetics. The neutralization assays can be used for titration of NAb in recovered/vaccinated or infected COVID-19 patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2174    
    Printed320    
    Emailed0    
    PDF Downloaded546    
    Comments [Add]    
    Cited by others 1    

Recommend this journal